A major international analysis has revealed that early-onset cancer rates are rising significantly faster among people under 50 than in older age groups across England, the United States and the Netherlands. The World Cancer Research Fund (WCRF) examined national cancer data from 2001 to 2023 and found dramatic increases in several cancer types in younger adults, with prostate cancer diagnoses among men under 50 in England quadrupling over the period.
FAKTA: Key findings at a glance
- Who studied it: the World Cancer Research Fund (WCRF) analysed national cancer-registration data from England, the United States and the Netherlands, comparing 2001 and 2023.
- Prostate cancer (England, under 50): quadrupled from about 1 case per 100,000 men in 2001 to 3.6 per 100,000 in 2023; annual cases rose from 158 to 640.
- Bowel cancer (England, under 50): more than doubled from 3.9 to 8.4 cases per 100,000; annual cases rose from 1,289 to 2,989.
- Kidney and uterine cancers (England, under 50): both roughly doubled — kidney to 3 per 100,000 and uterine to 3.9 per 100,000.
- Beyond England: significant increases in early-onset cancers for five cancer types in the US and four in the Netherlands.
- One exception: lung cancer declined among under-50s in all three countries as smoking rates fell.
- Preventable share: around 40 per cent of cancers are linked to modifiable risk factors such as obesity, diet and physical activity.
Prostate cancer leads the early-onset cancer surge in England
The sharpest rise was in prostate cancer. Of the twelve tumour types studied in England, diagnoses among men under 50 jumped from one in every 100,000 people in 2001 to 3.6 in every 100,000 in 2023. In absolute terms, that meant 640 cases in 2023 compared with 158 in 2001 — a fourfold increase that stunned researchers.
Bowel cancer told a similar story. Cases among younger adults climbed from 1,289 in 2001 to 2,989 in 2023, lifting the rate from 3.9 to 8.4 per 100,000. Kidney cancer cases more than doubled from 510 to 1,065, and uterine cancer among women rose from 335 to 698 cases.
| Cancer type (England, under 50) | Rate in 2001 | Rate in 2023 | Change |
|---|---|---|---|
| Prostate | 1.0 per 100,000 | 3.6 per 100,000 | Quadrupled |
| Bowel | 3.9 per 100,000 | 8.4 per 100,000 | More than doubled |
| Uterine | ~2.0 per 100,000 | 3.9 per 100,000 | Doubled |
| Kidney | ~1.5 per 100,000 | 3.0 per 100,000 | Doubled |
US and the Netherlands show the same pattern
The trend is not confined to England. In the United States, kidney cancer among people under 50 more than doubled after 2000, rising from 2.5 to 5.3 cases per 100,000 in 2023. Bowel, uterine and pancreatic cancers in younger Americans all rose by more than 50 per cent, while breast cancer increased by about 20 per cent.
The Netherlands recorded significant increases in early-onset bowel, kidney, liver and cervical cancers. Across all three countries, cancer among the under-50s remains relatively uncommon — the median age at diagnosis is still above 60 — but researchers say the trajectory is worrying because the rate of increase in younger adults exceeds that in older age groups.
What is driving the rise in early-onset cancer
No single cause has been proven. The WCRF points to the growing global obesity epidemic, poor diets, insufficient exercise, alcohol consumption, smoking and exposure to environmental pollutants as likely drivers. Excess body fat can cause chronic inflammation, altered hormone levels and harmful metabolic changes that promote cancer development over time.
But obesity alone cannot explain the whole picture. Scientists are also investigating changes in gut bacteria, exposure to certain toxic chemicals and plastics, antibiotic use and early-life exposures — areas that remain under active investigation. Better awareness and earlier diagnosis are also playing a role: in prostate cancer, some of the rise may reflect overdiagnosis, where a cancer is spotted that would never go on to cause harm.
To find answers, a new study called Prospect-UK launched in early October 2026 will track 250,000 people across the UK over time, gathering detailed diet and lifestyle data and linking participants to their NHS records.
A wake-up call for public health
Jon Shelton, head of cancer intelligence at Cancer Research UK, said cancer rates in people under 50 are rising both in England and worldwide. He noted that while the disease still mostly affects older people — with around half of UK cases diagnosed in those over 70 — higher rates of detection are likely playing a role, and that risk factors such as diet and being overweight or obese are likely to be impacting the trends. He added that more research is needed, which is why Cancer Research UK is funding the Prospect study to understand more about these cancers and how to prevent them.
Dr Giota Mitrou, the WCRF’s executive director of research and policy, said the figures should make everyone pause and think because the current trajectory is concerning. Mark Lawler, professor of digital health at Queen’s University Belfast, called the problem “a ticking timebomb” that needs to be diffused as quickly as possible, warning the numbers will undoubtedly continue to grow otherwise.
One bright spot emerged from the data: lung cancer is the exception, with incidence declining among the under-50s in all three countries as smoking rates fell — proof, experts say, that sustained public health action can reverse a trend.
Conclusion
The surge in early-onset cancer is a critical global health concern that can no longer be dismissed as a statistical quirk. With prostate cancer quadrupling and bowel, kidney and uterine cancers doubling or more among under-50s in England — and parallel rises in the US and the Netherlands — the findings point to lifestyle and environmental factors that demand a comprehensive public health response. International collaboration and sustained research funding, including the new 250,000-person Prospect-UK study, will be vital to understanding and ultimately reversing this alarming trend. For more on international health developments, see our World coverage and this story on our main site.
